Skip to main content
. 2018 Apr 24;8(6):773–778. doi: 10.3892/mco.2018.1616

Table I.

Demographic data of patients with cT1 gastric cancer.

Correct group (n=163) Underestimate group (n=30) P-value
Age (years) 68.0±10.2 66.0±13.1 0.777
Male/female 124/39 21/9 0.479
Body mass index 22.4±3.1 22.0±2.5 0.596
Tumor size (mm) 31.8±21.0 46.2±31.7 0.012
Tumor location
  Upper third 27 (16.6%) 10 (33.3%) 0.047
  Middle third 60 (36.8%) 12 (40.0%)
  Lower third 76 (46.6%)   8 (26.7%)
Circumferences
  Ant/post 37/61 5/15 0.278
  Gre/less 29/80 4/18 0.406
Tumor depth
  pT2 17 (56.7%)
  pT3 11 (36.7%)
  pT4 2 (6.7%)
Lymph nodal metastasis
  cN0 161 (84.7%) 29 (100%) 0.493
  cN1 3 (15.3%) 0 (0%)
Gross type
  Elevated 47 (28.7%) 5 (31.3%) 0.969
  Flat 12 (7.3%) 1 (6.3%)
  Depressed 105 (64.0%) 10 (62.5%)
Histology
  Intestinal type 115 (70.6%) 15 (50.0%) 0.027
  Diffuse type   48 (29.5%) 15 (50.0%)
Stroma
  Int 46 (66.7%) 13 (44.8%) 0.005
  Med 13 (18.8%)   3 (10.3%)
  Sci 10 (14.5%) 13 (44.8%)
Infiltrative growth
  a 11 (15.9%)   1 (3.5%) <0.001
  b 48 (69.6%) 13 (44.8%)
  c 10 (14.5%) 15 (51.7%)
Lymphatic invasion
  ly (−) 127 (77.4%) 8 (27.6%) <0.001
  ly (+) 37 (22.6%) 21 (72.4%)
Venous invasion
  v (−) 134 (81.7%) 7 (24.1%) <0.001
  v (+) 30 (18.3%) 22 (75.9%)

Data are expressed as the mean ± SD.